Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
deals
3
×
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
3
×
san francisco top stories
biotech ipos
boston blog main
boston top stories
cancer drugs
clinical trials
europe blog main
europe top stories
investing
medical device
national
national top stories
pfizer
startups
10x genomics
abbvie
acute myeloid leukemia
allergan aesthetics
alx oncology
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
autoimmune diseases
berkeley lights
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cd47
What
week
3
×
biotech
companies
ipo
life
science
street
wall
way
welcomed
acquisitions
arrival
biggest
bio
boost
build
buy
ceo
company’s
daniel
days
debut
drug
dyne’s
followed
genomics
gilead
hasn’t
haul
industry
ipos
led
market
markets
microbiome
momentum
moves
new
openly
o’day
Language
unset
Current search:
deals
×
biotech
×
week
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M